Adult–Gerontology Acute Care Nurse Practitioner Certification (AGACNP) Frances Practice Test

Cox-2 inhibitors, such as Celebrex, play a significant role in the management of osteoarthritis primarily by reducing stomach irritation when compared to traditional non-steroidal anti-inflammatory drugs (NSAIDs). Traditional NSAIDs, while effective in alleviating pain and inflammation, often lead to gastrointestinal side effects, including irritation and potential ulceration of the stomach lining.

Cox-2 inhibitors specifically target the cyclooxygenase-2 enzyme, which is responsible for the production of prostaglandins that mediate inflammation and pain. By selectively inhibiting this enzyme, these medications effectively manage pain and inflammation with a lower risk of gastrointestinal complications. This characteristic makes Cox-2 inhibitors a preferred option for many patients, especially those with a history of gastrointestinal issues, as they can provide the necessary anti-inflammatory and analgesic effects while minimizing harm to the stomach.

While providing daily pain management is a benefit of Cox-2 inhibitors, it is their safety profile concerning gastrointestinal irritation that distinguishes them from traditional NSAIDs. Options related to increasing inflammation or improving joint flexibility do not accurately reflect the intended therapeutic action of Cox-2 inhibitors in osteoarthritis treatment.